The applicant has recently described a disease characterized by nephrolithiasis, renal proximal tubular dysfunction, nephrocalcinosis, and ultimately renal failure, affecting only males and inherited in an X-linked recessive pattern. Despite extensive physiologic evaluation of these patients, no primary pathogenic abnormality could be identified for this disease, X-linked recessive nephrolithiasis (XRN). Hypercalciuria and low molecular-weight (LMW) proteinuria are common features of this disease, and the latter is also abnormal in nearly all carrier females. Nephrocalcin, a urinary protein that inhibits calcium stone crystallization, is structurally and functionally abnormal in carriers and patients with XRN. Similar families have been reported from Britain, Japan, Canada, and Italy. It is possible that this disease may represent some proportion of the population with idiopathic calcium nephrolithiasis or chronic renal disease. The applicant has localized the gene for XRN to a region spanning approximately three Mb on the short arm of the X-chromosome (Xpll.23), close to the gene for a similar disease in British families (""""""""Dent's disease"""""""") which maps to a different locus on Xp11.22. The present proposal aims to define the biochemical basis of XRN through cloning the gene using a positional cloning approach. The goals are to refine the genetic localization more precisely, then to construct a physical map of the region using YACs and P1 clones, and to identify candidate genes and screen them for mutations. The applicant plans to study expression and function of the gene for XRN and, if it is cloned during this period, the gene for Dent's disease as well. The applicant's research group has recently been strengthened with the addition of two individuals, both of whom have had extensive molecular experience directly relevant to the proposed work. As a secondary effort, clinical studies will be pursued in parallel, to study the abnormalities in the nephrocalcin produced in XRN, and to identify additional cases of XRN by screening several large populations of calcium stone-formers for low molecular-weight proteinuria, a sensitive marker for both XRN and Dent's disease. Mutations in the XRN gene will be sought in such additional cases. These clinical studies will be performed in Syracuse and in collaboration with colleagues at the University of Chicago, Northwestern University and the University of Pennsylvania. It is suggested by the applicant that elucidation of the pathophysiology of this disease should contribute to our understanding of both nephrolithiasis and chronic renal failure.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
1R01DK046838-01A2
Application #
2146098
Study Section
General Medicine B Study Section (GMB)
Project Start
1995-09-17
Project End
2000-08-31
Budget Start
1995-09-17
Budget End
1996-08-31
Support Year
1
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Upstate Medical University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
058889106
City
Syracuse
State
NY
Country
United States
Zip Code
13210
Hoopes Jr, Richard R; Raja, Khalid M; Koich, April et al. (2004) Evidence for genetic heterogeneity in Dent's disease. Kidney Int 65:1615-20
Knohl, Stephen J; Scheinman, Steven J (2004) Inherited hypercalciuric syndromes: Dent's disease (CLC-5) and familial hypomagnesemia with hypercalciuria (paracellin-1). Semin Nephrol 24:55-60
Norden, Anthony G W; Lapsley, Marta; Igarashi, Takashi et al. (2002) Urinary megalin deficiency implicates abnormal tubular endocytic function in Fanconi syndrome. J Am Soc Nephrol 13:125-33
Raja, Khalid A; Schurman, Scott; D'mello, Richard G et al. (2002) Responsiveness of hypercalciuria to thiazide in Dent's disease. J Am Soc Nephrol 13:2938-44
Norden, A G; Lapsley, M; Lee, P J et al. (2001) Glomerular protein sieving and implications for renal failure in Fanconi syndrome. Kidney Int 60:1885-92
Norden, A G; Scheinman, S J; Deschodt-Lanckman, M M et al. (2000) Tubular proteinuria defined by a study of Dent's (CLCN5 mutation) and other tubular diseases. Kidney Int 57:240-9
Scheinman, S J; Cox, J P; Lloyd, S E et al. (2000) Isolated hypercalciuria with mutation in CLCN5: relevance to idiopathic hypercalciuria. Kidney Int 57:232-9
Scheinman, S J; Guay-Woodford, L M; Thakker, R V et al. (1999) Genetic disorders of renal electrolyte transport. N Engl J Med 340:1177-87
Scheinman, S J (1999) Nephrolithiasis. Semin Nephrol 19:381-8
Schurman, S J; Norden, A G; Scheinman, S J (1998) X-linked recessive nephrolithiasis: presentation and diagnosis in children. J Pediatr 132:859-62

Showing the most recent 10 out of 12 publications